Spectroscopic Studies on the Interaction of Bilirubin with Liver Cystatin

Overview

Journal Eur Biophys J

Specialty Biophysics

Date 2010 Nov 25

PMID 21103869

Citations 4

Authors

Aaliya Shah

Bilqees Bano

Affiliations

Soon will be listed here.

Abstract

Studies on the role of endogenous metabolites such as bilirubin and their interactions with biomolecules have attracted considerable attention over the past several years. In this work, the interaction of bilirubin (BR) with purified goat liver cystatin (LC) was studied using fluorescence and ultraviolet (UV) spectroscopy. The fluorescence data proved that the fluorescence quenching of liver cystatin by BR was the result of BR-cystatin complex formation. Stern-Volmer analysis of fluorescence quenching data showed the binding constant to be 9.27 x 10⁴ M⁻¹ and the number of binding sites to be close to unity. The conformation of the BR-cystatin complex was found to change upon varying the pH of the complex. The BR-cystatin complex was found to have reduced papain inhibitory activity. Photo-illumination of BR-cystatin complex causes perturbation in the micro-environment of goat liver cystatin as indicated by red-shift. This report summarizes our research efforts to reveal the mechanism of interaction of bilirubin with liver cystatin.

Citing Articles

CST3 alleviates bilirubin-induced neurocytes' damage by promoting autophagy.

Li Z, Du Y Transl Neurosci. 2023; 14(1):20220314.

PMID: 37854583 PMC: 10579785. DOI: 10.1515/tnsci-2022-0314.

Differential effects of anti-cancer and anti-hepatitis drugs on liver cystatin.

Shah A, Priyadarshini M, Khan M, Aatif M, Amin F, Tabrez S Saudi J Biol Sci. 2015; 22(1):69-74.

PMID: 25561887 PMC: 4281580. DOI: 10.1016/j.sjbs.2014.06.006.

Bilirubin binding with liver cystatin induced structural and functional changes.

Mustafa M, Bano B J Fluoresc. 2014; 24(3):967-74.

PMID: 24711081 DOI: 10.1007/s10895-014-1381-4.

Studies on the chemical modification of goat liver cystatin and the effect on its anti-papain inhibitory activity.

Shah A, Aatif M, Priyadarshini M, Khan M, Amin F, Bano B J Fluoresc. 2012; 22(6):1627-32.

PMID: 22833218 DOI: 10.1007/s10895-012-1106-5.

References

Feng X, Lin Z, Yang L, Wang C, Bai C . Investigation of the interaction between acridine orange and bovine serum albumin. Talanta. 2008; 47(5):1223-9. DOI: 10.1016/s0039-9140(98)00198-2. View

Trabandt A, Gay R, Fassbender H, Gay S . Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1991; 34(11):1444-51. DOI: 10.1002/art.1780341116. View

Delaisse J, LEDENT P, Vaes G . Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Biochem J. 1991; 279 ( Pt 1):167-74. PMC: 1151563. DOI: 10.1042/bj2790167. View

Jacobsen J, Wennberg R . Determination of unbound bilirubin in the serum of newborns. Clin Chem. 1974; 20(7):783. View

Khan M, Tayyab S . Understanding the role of internal lysine residues of serum albumins in conformational stability and bilirubin binding. Biochim Biophys Acta. 2001; 1545(1-2):263-77. DOI: 10.1016/s0167-4838(00)00288-0. View

BONNETT R, Davies J, Hursthouse M . Structure of bilirubin. Nature. 1976; 262(5566):327-8. DOI: 10.1038/262326a0. View

KUNITZ M . CRYSTALLINE SOYBEAN TRYPSIN INHIBITOR : II. GENERAL PROPERTIES. J Gen Physiol. 2009; 30(4):291-310. PMC: 2142836. DOI: 10.1085/jgp.30.4.291. View

Barrett A, Fritz H, Grubb A, Isemura S, Jarvinen M, Katunuma N . Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J. 1986; 236(1):312. PMC: 1146824. DOI: 10.1042/bj2360312. View

Hansen T, Bratlid D . Bilirubin and brain toxicity. Acta Paediatr Scand. 1986; 75(4):513-22. DOI: 10.1111/j.1651-2227.1986.tb10242.x. View

10.

North M, Mottram J, Coombs G . Cysteine proteinases of parasitic protozoa. Parasitol Today. 1990; 6(8):270-5. DOI: 10.1016/0169-4758(90)90189-b. View

11.

Ekiel I, Abrahamson M, Fulton D, Lindahl P, Storer A, Levadoux W . NMR structural studies of human cystatin C dimers and monomers. J Mol Biol. 1997; 271(2):266-77. DOI: 10.1006/jmbi.1997.1150. View

12.

Karp W . Biochemical alterations in neonatal hyperbilirubinemia and bilirubin encephalopathy: a review. Pediatrics. 1979; 64(3):361-8. View

13.

Koppel P, Baici A, Keist R, Matzku S, Keller R . Cathepsin B-like proteinase as a marker for metastatic tumor cell variants. Exp Cell Biol. 1984; 52(5):293-9. DOI: 10.1159/000163273. View

14.

Jacobsen J, Brodersen R . Albumin-bilirubin binding mechanism. J Biol Chem. 1983; 258(10):6319-26. View

15.

Schmid R . Bilirubin metabolism: state of the art. Gastroenterology. 1978; 74(6):1307-12. View

16.

Tayyab S, Qamar S, Islam M . Effect of acetylation on conformation and bilirubin-binding properties of goat serum albumin. Int J Biol Macromol. 1995; 17(1):33-5. DOI: 10.1016/0141-8130(95)93515-y. View

17.

Ostrow J, MUKERJEE P, Tiribelli C . Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res. 1994; 35(10):1715-37. View

18.

Harmatz D, BLAUER G . Optical properties of bilirubin-serum albumin complexes in aqueous solution. A comparison among albumins from different species. Arch Biochem Biophys. 1975; 170(2):375-83. DOI: 10.1016/0003-9861(75)90132-0. View

19.

Bernstein H, KIRSCHKE H, Wiederanders B, Pollak K, Zipress A, Rinne A . The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review. Mol Chem Neuropathol. 1996; 27(3):225-47. DOI: 10.1007/BF02815106. View

20.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View